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Abstract
Varying concentrations of lipopolysaccharide (LPS) in ovalbumin (OVA) may influence the airway response to allergic
sensitization and challenge. We assessed the contribution of LPS to allergic airway inflammatory responses following
challenge with LPS-rich and LPS-free commercial OVA. BALB/c mice were sensitized with LPS-rich OVA and alum and then
underwent challenge with the same OVA (10 mg intranasally) or an LPS-free OVA. Following challenge, bronchoalveolar
lavage (BAL), airway responsiveness to methacholine and the lung regulatory T cell population (Treg) were assessed. Both
OVA preparations induced BAL eosinophilia but LPS-rich OVA also evoked BAL neutrophilia. LPS-free OVA increased
interleukin (IL)-2, IL-4 and IL-5 whereas LPS-rich OVA additionally increased IL-1b, IL-12, IFN-c, TNF-a and KC. Both OVA-
challenged groups developed airway hyperresponsiveness. TLR4-deficient mice challenged with either OVA preparation
showed eosinophilia but not neutrophilia and had increased IL-5. Only LPS-rich OVA challenged mice had increased lung
Tregs and LPS-rich OVA also induced in vitro Treg differentiation. LPS-rich OVA also induced a Th1 cytokine response in
human peripheral blood mononuclear cells.We conclude that LPS-rich OVA evokes mixed Th1, Th2 and innate immune
responses through the TLR-4 pathway, whereas LPS-free OVA evokes only a Th2 response. Contaminating LPS is not
required for induction of airway hyperresponsiveness but amplifies the Th2 inflammatory response and is a critical mediator
of the neutrophil, Th1 and T regulatory cell responses to OVA.
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Introduction
Allergen exposure is well recognized to participate in the
induction of asthma. [1] Since the pioneering studies of Mosmann
and colleagues, distinguishing two T helper subsets as Th1 and
Th2 types [2], extensive studies on model systems of asthma have
implicated a Th2 biased immune response in the pathogenesis of
the disease. Over-expression of Th2 cytokines has also been
confirmed in human asthmatic tissues and in induced sputum.
[3,4] Epidemiological studies have revealed a protective effect of
large family size on the development of asthma, triggering the idea
of the hygiene hypothesis in the protection against asthma. [5]
Living in a rural environment with exposure to farm animals early
in life was also shown to be protective against allergy and asthma.
[6] High levels of endotoxin associated with this environment have
been suggested to modulate innate immunity via Toll-like
receptors (TLRs) and to promote the maturation of an immune
system that is less predisposed to Th2 responses to innocuous
aeroallergens. [7].
The complex mechanisms leading to Th2 immune responses to
sensitization with allergen have been dissected using murine
models that readily develop several of the characteristics of
asthma, including eosinophilic inflammation and airway hyperre-
sponsiveness following sensitization and challenge with allergen.
[8–11] Dendritic cell processing of antigen and CD4+ T cell
activation is the principal mechanism by which airway inflamma-
tory responses to allergen are initiated. [12] Dendritic cell derived
cytokines are key in determining the nature of the T cell response,
whether Th1 or Th2 [12], Treg or Th17. [13] Other factors, such
as cysteinyl-leukotriene production by dendritic cells [14] as well
as basophil, mast cell and T cell derived cytokines may also alter
the airway milieu in a way that favours Th2 differentiation. [15–
17].
Innate immune mechanisms are required for dendritic cell
priming to occur [12] and to cause effective Th2 responses to
sensitization with ovalbumin. [18] Commercial OVA is known to
be LPS-rich and the contamination appears to be of sufficient
magnitude to affect allergic responses. [19] Previous studies have
examined the effect of the contaminating LPS in ovalbumin or
addition of exogenous LPS on the allergic sensitization process
(whether intraperitoneal or intranasal) as well as subsequent
allergen challenge. [18–22] Collectively, these studies have shown
that the contaminating LPS and TLR4 signaling are necessary for
PLOS ONE | www.plosone.org 1 June 2014 | Volume 9 | Issue 6 | e98648
priming pro-inflammatory T helper cell responses to inhaled
ovalbumin and that the level of LPS exposure in conjunction with
ovalbumin determines whether a Th2, Th1, Th17 and/or T
regulatory cell response is elicited. [18,20–23] In contrast,
Watanabe et al. reported that the contaminating LPS in
commercial ovalbumin preparations inhibited the development
of allergic airway disease, though it is not clear whether this effect
may have been related to the systemic co-exposure to LPS during
sensitization rather than the pulmonary exposure during chal-
lenge. [19,24] What, if any, effect the contaminating LPS in
commercial ovalbumin preparations has specifically in relation to
the secondary allergen exposure or ‘‘challenge’’ in animals which
have been equivalently sensitized has not been examined to date.
Furthermore, unlike intranasal ovalbumin sensitization, intraper-
itoneal sensitization with the adjuvant aluminum hydroxide in
conjunction with ovalbumin has been shown to activate dendritic
cells via the nucleotide-binding domain, leucine-rich repeat
containing protein family, pyrin domain containing 3 (NLRP3)
[25], bypassing the need for TLR-4 activation by LPS [21] in the
induction of allergic airway disease. However, it is not known
whether the contaminating LPS may still modulate the airway
inflammatory response, even if it is not required for the
manifestation of experimental asthma in these so-called ‘‘alum-
based’’ allergy models. The aim of the present study was thus to
contrast the airway responses to OVA by comparing LPS-rich and
LPS-free OVA specifically during allergen challenge in a murine
model of allergic asthma. For this purpose we assessed lung
mechanical responses to methacholine challenge and the inflam-
matory response evoked by OVA. We also assessed the degree to
which regulatory T cells were induced in response to OVA
challenge and the effects of the TLR4 inhibitor, TAK242, on
in vitro Treg induction in splenocytes. TLR4-deficient mice were
also used to evaluate the role of TLR4 in vivo in the modulation of
airway inflammation by contaminating LPS. Finally we measured
the responses of peripheral blood mononuclear cell responses of
normal human volunteers to incubation with LPS-free and LPS-
containing OVA to assess the role of immune effector cells on
cytokine responses to LPS-rich OVA.
Methods
Assessment of endotoxin levels in OVA
Endotoxin levels were assessed in two sources of OVA; Sigma
Grade V OVA (LPS-rich) Sigma, St Louis MO or Dorset, UK and
Endograde-OVA (LPS-free) (Hyglos Gmbh, Regensburg, Ger-
many) using two methods. The first was the Limulus Amebocyte
Lysate Pyrogent Single Test Vials (Lonza, Walkersville, MD, USA)
with a maximum sensitivity of 0.06 EU/ml, this was used to
qualitatively test for the presence of LPS in both samples. Five
different concentrations of Sigma and Hyglos OVA were tested for
the presence of LPS (10 mg/ml, 1 mg/ml, 100 ng/ml, 10 ng/ml,
1 ng/ml). LAL reagent water was used as a negative control and
0.25 ml of each sample was added to the test vials containing
lysates from washed amebocytes, following the manufacturer’s
instructions. A positive outcome was detected as a firm gel
formation in the test vial after inversion.
To obtain a more quantitative assessment of endotoxin levels we
used the ToxinSensor Chromogenic LAL Endotoxin Assay Kit
(GenScript, Piscataway, NJ, USA) with a sensitivity range of
0.005–1 EU/ml. Concentrations of Sigma-OVA ranging from
0.1 ng/ml to 100 ng/ml, and five concentrations of Hyglos-OVA
ranging from 10 mg/ml to 100 ng/ml were used to evaluate LPS
content. First, 100 ml of LAL was added to 100 ml of each sample
followed by an incubation period of 45 minutes at 37uC.
Following the incubation period, 100 ml of chromogenic substrate
was added to each sample vial followed by 6 minutes incubation at
37uC. Following incubation, 500 ml of stop solution, 500 ml of
color stabilizer 2 and 500 ml of color stabilizer 3 were added to
each sample. Absorbance was measured at 550 nm using a plate
reader (ELx808 Absorbance Microplate Reader, BioTek, Wi-
nooski, VT). LPS concentrations in Sigma-OVA and Hyglos-
OVA were determined using standard curves obtained from
different concentrations of LPS (0.1 EU/ml, 0.04 EU/ml,
0.02 EU/ml, 0.01 EU/ml, 0.005 EU/ml). No LPS was detected
in the negative control.
Animal preparation
Male BALB/c mice were obtained from Charles River
Laboratories (Saint-Constant, Quebec, Canada) and Charles
River Laboratories (Margate, UK) and were studied between the
ages of 6–8 weeks. DO.11.10 mice, ovalbumin specific TCR
transgenic mice with BALB/c background, and TLR4 deficient
(BALB/c background) mice were bred in the animal care facility of
McGill University Health Centre. All animals were housed in
conventional animal facilities at McGill University and University
College Cork and were cared for in compliance with the Canadian
Council of Animal Care’s guide; protocols and procedures were
approved animal ethics committees of McGill University, Mon-
treal, Canada and University College Cork, Ireland.
Allergic sensitization and challenge protocol
The sensitization and challenge protocol used in this study is
shown in supplementary figure 1. Briefly, all groups were
sensitized with an i.p. injection of a phosphate-buffered saline
(PBS) (Invitrogen, Paisley, Scotland or USA) solution containing
10 mg OVA (Grade V, Sigma) with 1 mg of adjuvant aluminum
hydroxide, Al(OH)3 (Fisher Scientific, Ottawa, ONT, Canada).
Sensitization was performed on two separate days; day 0 and day
7. One week following the second sensitization, mice were
challenged once or on three consecutive days via an intra-nasal
instillation of 10 mg of LPS-rich OVA or LPS-free OVA in 50 ml
of saline under light isoflurane anaesthesia. One day after the
single challenge and two days following the three challenges,
experiments were performed. Control mice were challenged with
PBS.
Measurement of in vivo respiratory mechanics
Measurements of mechanics were made after three challenges
only, as airway hyperresponsiveness (AHR) is inconsistently
induced by a single challenge only. For this purpose, mice were
injected i.p. with xylazine (10 mg/kg) and pentobarbital sodium
(30 mg/kg). Mice were tracheostomized and an 18-gauge tracheal
metal cannula was inserted and firmly tied. Subsequently, the
animal was connected to a computer controlled small animal
ventilator (Flexivent, Scireq Inc. Montreal, Canada) and normal
tidal breathing was initiated. Mice were mechanically ventilated
with a tidal volume of 10 ml/kg at a PEEP of 3 cm H2O and a
frequency of 150 breaths/minute. Animals were then paralyzed
with pancuronium bromide (1.2 mg/kg), administered i.p., prior
to the measurement of respiratory mechanics.
Respiratory mechanics were measured using the flexiVent
(SCIREQ Inc., Montreal, Canada) small animal mechanical
ventilator. Briefly, total respiratory system resistance (Rrs) and
elastance (Ers) were calculated by fitting the equation of motion of
the linear single compartment model of lung mechanics to the data
recorded from a 1.2 second, 2.5 Hz single-frequency forced
oscillation perturbation, using multiple linear regression. Mea-
surements were obtained at baseline as well as after the delivery of
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aerosols of increasing concentrations (20, 40, 80, 160 mg/ml in
PBS) of methacholine (MCh; Sigma). Aerosols were delivered to
the airways via an ultrasonic nebulizer for a period of 5 seconds
(Aeroneb Lab, Aerogen Ltd, Ireland). Perturbations were executed
every 8 seconds until the peak Rrs and Ers was observed for a
given dose of MCh, and the process was repeated for each
subsequent dose. The average of these values (peak Rrs and Ers)
for each experimental group was then plotted.
Bronchoalveolar lavage
Bronchoalveolar lavage (BAL) was performed immediately
following single OVA challenge or, in the case of the three
OVA challenges, following mechanics measurements. BAL was
carried out using two aliquots of cold saline (1 ml) via the tracheal
cannula. Supernatant from the first BAL sample for each animal
was stored at 280uC for subsequent cytokine/chemokine analysis.
Cell pellets were pooled and reconstituted in PBS for the
determination of total viable cell counts and for cytospin
preparations (Shandon, Cheshire, UK). Cytospins were stained
with Diff-Quick (Fisher Scientific). Differential cell counts were
then determined from a count of three hundred cells.
Flow cytometric analysis of lung T helper and regulatory
cells
We assessed the CD4+ T cell numbers and CD4+CD25+
FoxP3+ cells in the lungs of animals undergoing three OVA
challenges. Following the assessment of methacholine responsive-
ness and BALF collection, the right lung of each animal was
excised and placed in cold RPMI-1640 medium, containing 8%
heat-inactivated FBS, 2 mM L-glutamine, 50 mg/ml gentamycin
and 10 mM HEPES (Invitrogen, USA.). The lung was removed
from the medium and transferred to a dish containing 4 ml of
sterile DPBS (Invitrogen) supplemented with collagenase (0.2
Wunsch units/ml, Clostridium histolyticum, Type XI-S, Sigma),
DNAse I (1000 DNase units/ml, Type II-S, Sigma) and 0.5 mM
calcium. The lung was also inflated with 1 ml of the same solution,
minced with forceps and a scalpel blade and incubated on an
orbital shaker at 37uC for 1 hour. The reaction was stopped with
5 ml cold RPMI-1640 medium (as above) with 2 mM EDTA
(Invitrogen,) and 50 mM b-mercaptoethanol (Sigma). The lung
tissues were mechanically disrupted, passed through 70 mm and
40 mm BD Falcon cell strainers and finally centrifuged at
1500 rpm for 5 min. Red blood cells were lysed with ammonium
chloride and leukocytes were counted using a Beckman Coulter
Ac.T Counter. Cells were incubated with mouse BD Fc Block (BD
Biosciences, Canada), then stained with FITC-conjugated rat anti-
mouse CD4 mAb (clone H129.19), followed by PE CD25 (clone
PC61), or the appropriate isotype control Ab (BD). Cells were then
fixed with BD Cytofix/Cytoperm solution, incubated with 1%
BSA in BD Perm/Wash solution and finally stained with APC
Foxp3 mAb (clone FJK-16s) or isotype control Ab (eBioscience,
San Diego, CA, USA). 50000 events were acquired for each
condition using the BD FacsCalibur (Becton Dickinson). Cells
were gated first based on CD4-positivity (vs side scatter) and then
based on forward scatter (vs side scatter) to exclude debris or small
dead cells.
Splenocyte culture and OVA stimulation
Spleens from 8–10 week DO.11.10 mice were harvested and a
single cell suspension was prepared as described for lung tissue
above. Splenocytes were cultured in 24-well plates, 56106 cell/ml,
for 3 days in RPMI 1640 supplemented with 10% FBS and
penicillin, 100 I.U/ml, streptomycin, 100 ug/ml, L-glutamine,
2 mM, (all reagents were purchased from Invitrogen), with either
OVA–LPS free or OVA-LPS rich and with or without TLR-4
inhibitor (TAK-242, InvivoGen, Cedarlane labs, Ontario, Ca-
nada). Cells were analyzed by flow cytometry as described above.
Isolation and stimulation of human peripheral blood
mononuclear cells
Human peripheral blood mononuclear cells (PBMC) were
isolated from 6 healthy human male volunteers with the approval
of the Ethics Committee of University College Cork. Nine mls of
venous blood was isolated in sterile EDTA vacutainers (BD). The
blood was mixed with an equal volume of PBS (Invitrogen),
layered over 20 mls of Histopaque (Sigma) and centrifuged for
400 g for 30 minutes. The buffy coat was removed from the
interface and washed twice by centrifugation (10 min at 300 g)
using DMEM (Invitrogen), 10% fetal calf serum (Sigma) and 1%
penicillin-streptomycin (Invitrogen). PBMC viability and cell
number was evaluated using the Countess automated cell counter
(Invitrogen) and were re-suspended in complete media at
16106 cells/ml. PBMCs were stimulated for 20 hrs with ultrapure
LPS (100 ng/ml) (E coli 0111:B4, InvivoGen), LPS-rich OVA
(100 ng/ml) and LPS-free OVA (100 ng/ml). Supernatants were
collect for cytokine analysis.
Bronchoalveolar Lavage Fluid (BALF) and PBMC
supernatant cytokine assay
IFN-c, IL-1b, IL-2, IL-4, IL-5, KC (CXCL1), IL-10, IL-12p40
and TNF-a levels were quantified using an electro-chemilumines-
cence multiplex system Sector 2400 imager from Meso Scale
Discovery (MSD) (Gaithersburg, MD, USA) where antibodies
labelled with a Sulfo-tag emitted light upon electrochemical
stimulation. MSD ultra-senstitive kits for murine (BALF) or human
PBMC samples were used respectively.
Statistical analyses
The experiments performed on wild type BALB/c mice
characterizing inflammatory responses to OVA sensitization and
challenge were reproduced in both the laboratories of the
investigators in Ireland and Canada. The data presented in the
manuscript are a representative dataset. The experiments charac-
terizing respiratory mechanics and those on the TLR4 deficient
and the DO.11.10 mice were performed in Canada only.
Experiments were usually performed over several days with all
experimental groups represented on any given day.
Data are expressed throughout as the mean +/2 standard error
of the mean. Comparison among means was performed using
ANOVA with Tukey’s post hoc test for multiple comparisons. For
lung mechanics ANOVA with Bonferroni’s multiple comparison
test was used. When data were not normally distributed the
analyses were performed on log transformed data.
Results
Commercial OVA contains high level of endotoxin
LPS content of both OVA samples was determined using the
Limulus Amebocyte Lysate (LAL) agglutination single test vial to
qualitatively test for the presence of LPS in the two commercial
sources of OVA that we explored. Using this test we demonstrated
the presence of LPS in the Sigma-OVA (LPS-rich OVA) whereas
there was no LPS detected in the Hyglos-OVA (LPS-free). To
obtain a more quantitative assessment of LPS levels we used the
LAL Chromogenic Assay and we found that LPS-rich OVA
contained on average 400 ng endotoxin/10 mg OVA, while LPS-
LPS Contaminated OVA Increases Inflammation in Murine Asthma
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free OVA had undetectable levels (Figure S1). Four different
batches of Sigma-OVA were tested for endotoxin and the results
demonstrated a range of concentrations from 75 ng to 1415 ng/
10 mg OVA.
AHR after OVA challenge is minimally further increased
by LPS-rich OVA
The effects of LPS-rich OVA and LPS-free OVA on the
induction of AHR to MCh were evaluated in animals that were
challenged with OVA on three consecutive days and had MCh
challenge two days later (Figure S2). Respiratory resistance (RRS)
was significantly greater in LPS-rich OVA challenged mice
following administrations of MCh in concentrations of 40, 80
and 160 mg/ml and also in LPS-free OVA challenged mice at 80
and 160 mg/ml concentrations of MCh, in comparison with PBS
challenged controls (Fig. 1A). Animals challenged with LPS-free
OVA only differed in their responsiveness (RRS) at the highest
MCh concentration (160 mg/ml) compared to LPS-rich OVA
challenged mice (16.7161.86 vs. 24.5462.67 cm H2O.s/ml
respectively).
Total respiratory elastance (ERS) was also significantly greater in
LPS-rich OVA challenged mice at MCh 40 mg/ml, 80 and
160 mg/ml and LPS-free OVA challenged mice (at 80, and
60 mg/ml) compared to PBS controls (Fig. 1B). However, in
contrast to the RRS, ERS responses of LPS-rich OVA and LPS-free
OVA challenged groups were not different in response to
increasing concentrations of MCh.
Contaminating LPS induces neutrophilia and increases
BALF cellularity in wild type but not TLR4 deficient mice
We assessed the differences in inflammatory response induced
by OVA challenge at 24 hrs after a single OVA exposure and
48 hrs following three OVA challenges in both wild type and
TLR4 deficient mice. There was a significant increase in total cell
counts in the BALF of LPS-rich OVA challenged animals
compared to both the saline control and the LPS-free OVA in
wild type animals (Fig. 2A). LPS-free OVA challenge did not
significantly alter the total cell number. Challenge of TLR4
deficient mice with LPS-free and LPS-rich OVA increased total
cell counts (Fig. 2A). There was an increase in eosinophil numbers
following challenge with both preparations of OVA but the LPS-
rich OVA caused a relatively greater eosinophilia in wild type
mice, (Fig. 2B). TLR4 deficient mice also had increased eosinophil
numbers from both OVA preparations, (Fig. 2B). In wild type
mice LPS-rich OVA also evoked increases in neutrophil and
lymphocyte numbers that were not seen with LPS-free OVA
(Fig. 2C, D). Lymphocyte numbers were also increased in the
TLR4 deficient mice, but by both OVA types, however no change
in neutrophils numbers was observed, (Fig. 2C, D). Macrophage
numbers did not change between the LPS-rich OVA and saline
challenged groups, however the macrophages were significantly
fewer in the LPS-free OVA challenged group compared to saline
and LPS-rich OVA challenge (Fig. 2E). LPS-rich OVA also
induced an increase in macrophage numbers in TLR4 deficient
mice, (Fig. 2E), however LPS-free OVA did not.
LPS-rich OVA induces a mixed Th2 and inflammatory
response in the bronchoalveolar lavage
The Th-2 cytokines, IL-2, IL-4 and IL-5, were increased in the
wild type BAL fluid harvested at 24 hr after a single challenge of
both groups with OVA (Fig. 3A–C). However the changes in IL-4
and IL-5 were greater in the group challenged with LPS-rich OVA
compared to the LPS-free OVA challenged group. LPS-rich OVA
also induced IFN-c while LPS-free did not (Fig. 3D). LPS-rich
OVA induced, in addition to the Th2 cytokines, increases in the
inflammatory cytokines/chemokines; IL-12p40, IL-1b, TNF-a,
and KC, the murine ortholog of IL-8, (Fig. 3E–H). No significant
change in these mediators was observed in the LPS-free OVA
challenged group. In the TLR4-deficient mice, no increase in IL-4
(Fig. 3B), was observed however IL-5 was induced to the same
degree by the two OVA preparations (Fig. 3C). IL-2 and IFNc
were undetectable in the challenged TLR4-deficient mice BAL
fluid. No increases in the inflammatory cytokines, IL-12p40, IL-
1b, TNF-a, and KC were observed (Fig. 3E–F).
OVA challenge increase helper T cells but only LPS-rich
OVA increases Treg recruitment to the lung
Challenge of wild type mice with LPS-rich OVA, following
three challenges, resulted in a significantly higher total lung cell
count compared to both saline and LPS-free OVA (Fig. 4A). The
total CD4+ cell numbers present in the lung were also elevated
following LPS–rich challenge (Fig. 4B). The percentage of CD4+
cells that were CD25+ Foxp3+ in the LPS-rich challenged group
Figure 1. Contaminating LPS increases airway resistance to
OVA following metacholine challenge. (a) Lung resistance in LPS-
rich and LPS-free OVA challenged mice 48 hours following three OVA
challenges, LPS rich OVA increased Lung resistance. (b) Lung elastance
compared to saline control in both LPS-rich and LPS-free OVA
challenged mice as per (a). Mice were sensitized with OVA on day 0
and 7 and challenged intra-nasally with either LPS-free or LPS-rich OVA
on day 14, 15, 16 and assessed for lung mechanics on day 18. * OVA-LPS
rich vs. PBS, + OVA-LPS free vs. PBS, # OVA-LPS free vs. OVA-LPS rich.
Number of symbols denotes signficance, e.g, *** = P,0.001, Values are
shown as Mean 6 SEM, N= 8. Statistical significance was determined
using ANOVA.
doi:10.1371/journal.pone.0098648.g001
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was elevated and there was also an increase in the number of
activated CD4+ T cells (CD25+ Foxp32) (Fig. 4C). LPS-free OVA
challenged mice did not have increased Tregs but did have
increased activated helper T cells (CD4+CD25+) compared to
saline (Fig. 4D). LPS-rich OVA also induced Treg differentiation
in vitro, in splenocyte cultures from DO.11.10 mice, while LPS-free
OVA did not; this effect was inhibited by adding the TLR4
inhibitor, TAK-242 (Fig. 4E).
Figure 2. LPS contaminated OVA induces neutrophilia in bronchoalveolar lavage fluid (BALF) in wild type mice but not in TLR4
deficient mice. Mice were treated as describe in Fig. 1, with three OVA challenges, and leukocytes were identified by morphological criteria and
staining. (a) Total BALF cells in sensitized mice, following challenge with saline, LPS-rich OVA and LPS-free OVA. (b) Total eosinophils in BALF. (c) Total
lymphocytes in BALF. (d) Total neutrophils in BALF. (e) Total macrophages in BALF. Values are shown as Mean 6 SEM. (n = 8). Statistical significance
was determined using ANOVA.
doi:10.1371/journal.pone.0098648.g002
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Figure 3. LPS contaminated OVA increase Th2 and Th1 cytokine levels in the BALF following nasal challenge in wild type mice but
not in TLR4 deficient mice. BALF cytokines were analysed using MSD electrochemical ELISA as described in the methods. Th2 cytokine levels
secreted into the BALF of mice following three challenges with LPS-rich or LPS-free OVA, were assayed IL-2 (pg/ml) (a), IL-4 (b), IL-5 (c) and IFN-c (d).
Th1 cytokine levels secreted into the BALF of mice following three challenges with LPS-rich or LPS-free OVA, IL-12p40 (pg/ml) (e), IL-1b (f), TNFa (g)
and KC (h). Not detectable (ND). Values are shown as Mean 6 SEM. (n = 8). Statistical significance was determined using ANOVA.
doi:10.1371/journal.pone.0098648.g003
Figure 4. OVA challenge increases lung CD25+Foxp32 T (helper) cells while LPS-rich OVA also induces CD25+Foxp3+ T (reg)
recruitment. Mice were treated as described in Fig. 1. Lung digests were performed, as described in the methods, cell populations were analysed by
flow cytometry. (a) Total cell counts, (b) Total CD4+ T cell, (c) CD4+ CD25+Foxp3+ (Treg) cells and (d) CD4+CD25+ Foxp32 (activated T cells) in lung
digests of sensitized mice following three challenges with saline, LPS-rich OVA and LPS-free OVA. (e) in vitro splenocyte Treg induction in the
presence of the TAK-242 inhibitor with or without LPS-rich OVA and LPS-free OVA. Values are shown as Mean 6 SEM. (n = 7). Statistical significance
was determined using ANOVA.
doi:10.1371/journal.pone.0098648.g004
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LPS-rich OVA induces an inflammatory cytokine response
in Human PBMCs while LPS-free OVA does not
It is possible that TLR4 on structural or immune effector cells
might be responsible for conditioning T cell responses to LPS-rich
OVA. Therefore we wished to determine whether the LPS-rich
OVA evoked different responses in human PBMCs. Following
incubation of PBMC for 20 hrs with either LPS-free OVA, LPS-
rich OVA or control LPS (E. coli LPS, 100 ng/ml) the pro-
inflammatory cytokines, IL-12p40, TNF-a, IFN-c and IL1-b, were
measured. LPS-rich OVA significantly induced all four Th1
cytokines with levels above that or comparable to the positive
control LPS (Fig. 5A–D). LPS-free OVA did not induce any
cytokine response from the PBMCs. IL-2, IL-4, IL-5 and IL-10
levels were also increased by LPS-rich OVA but not LPS-free
OVA (Fig. 5E–H).
Discussion
There is abundant evidence that activation of the TLR pathway
conditions subsequent responses to sensitization with soluble
antigens. We evaluated the importance of LPS contamination in
commercial OVA on the secondary inflammatory response evoked
in a murine model of allergic asthma. There were substantial
differences in the cellular and mediator responses to airway
exposure to OVA in the presence and absence of LPS. In the
context of sensitization using alum adjuvant, LPS modulates the
inflammatory response, but is not necessary for ‘‘disease’’
development, as defined by the induction of airway hyperrespon-
siveness. Differences in inflammation induced by inhalational
challenge with LPS-rich OVA and LPS-free OVA appear to be
accounted for by signaling through the TLR4.
The endotoxin/LPS detected in the two commercial OVA
preparations was evaluated using two assays, clot based and
colorimetric. Both assays, although differing in sensitivity demon-
strated the presence of endotoxin in the OVA that was not purified
and its absence in the commercial LPS-free preparation. The LPS-
rich OVA contained approximately 4 mg endotoxin/mg OVA.
There was substantial batch-to-batch variation in the degree of
endotoxin contamination. The levels of endotoxin detectable in
relation to bacterial colony forming units (CFU) would suggest at
least 26106 CFU of bacteria equivalents. [26] In a previous study
Watanabe et al. [19] estimated the levels of endotoxin present in
the same commercial source of OVA at 10 mg/mg, while our
estimates indicated a comparable, substantial LPS contamination.
Airway challenge with LPS-rich OVA resulted in a substantially
enhanced inflammation compared to challenge with LPS-free
OVA. Both inflammatory and Th2-associated cytokines were
augmented above the effects of OVA alone by the concomitant
LPS challenge associated with commercial LPS-rich OVA. An
increase in Tregs in lung digests was also observed following OVA
challenge but only when associated with LPS. Despite the
differences in inflammatory cells, cytokines and Tregs in the
pulmonary response of LPS-rich OVA challenged animals, there
was only a minor difference in the airway responses to inhaled
aerosols of methacholine, and the difference was attributable to a
slightly reduced degree of responsiveness of the larger conducting
airways as reflected in respiratory system resistance. The changes
were not detectable in respiratory system elastance, which is more
sensitive to peripheral airway responses. A previous study [19]
showing that endotoxin contamination of OVA reduced the
hyperresponsiveness to methacholine induced by OVA in contrast
to our findings but used the Penh technique, which is not a
measure of airway resistance but rather reflects changes in
breathing pattern that may or may not follow changes in
respiratory mechanics. [27] Likewise, mice lacking lipopolysac-
charide binding protein, an accessory molecule that is important
for the affinity of LPS binding to TLR-4 [28], have reduced OVA
induced airway responsiveness but again measured by the Penh
technique [29]. A recent study on the BN rat undergoing repeated
challenges with LPS-rich and LPS-free OVA demonstrated
comparable airway smooth muscle remodeling in the large
airways. [30].
Both OVA challenged groups showed substantial sensitization
to OVA but there was, in general, an augmented inflammatory
response to LPS-rich OVA challenge. An eosinophil-rich inflam-
mation followed challenge in both OVA challenged groups but it
was more pronounced after LPS-rich OVA exposure. Low dose
LPS has been shown previously to augment eosinophilic inflam-
mation in mice sensitized intranasally with LPS-free OVA. [20]
Low dose systemic LPS has similar effects on pulmonary
eosinophilia. [30] However, mice lacking lipopolysaccharide
binding protein, reportedly mount comparable degrees of eosin-
ophilia in response to OVA challenge to wild type controls,
although they do not develop allergen-induced airway hyperre-
sponsiveness. [29] However, the administration of exogenous LPS
to OVA challenged C57Bl/6 mice is inhibitory of eosinophilia
[20] as is high dose LPS challenge of BALB/c mice [25],
indicating that the timing, route of administration, origin and dose
of LPS may have important influences on the outcome of the
challenge. In the current study there was also a neutrophilic
response, a marked lymphocytosis and an increase in macrophage
numbers in the LPS-rich OVA challenged mice, not seen in LPS-
free OVA challenged wild type animals. The BALF neutrophilia
was also absent in TLR4-deficient mice. These data suggest
substantial differences in the synthesis and secretion of chemoat-
tractant molecules, chemokines and lipid mediators in the OVA
challenged groups, due to the presence of contaminating LPS. Our
observations with the TLR4-deficient mice confirm the observa-
tions of Strohmeier et al. [29], that LPS is not needed for OVA to
induce eosinophilia and also confirms that contaminating LPS
exacerbates inflammation in the wild type animals.
The BALF cytokine mediator levels, in the wild type mice, were
different in the two OVA challenged groups, consistent with the
differences in cellular influx that we observed. There appeared to
be similar levels of T cell activation as reflected in the levels of IL-
2. However, the Th2 cytokines IL-4 and IL-5 were more highly
expressed in the LPS-rich OVA challenged animals. Somewhat
paradoxically the inflammatory cytokine IFN-c was also increased
in expression in the LPS-rich OVA challenged animals. There was
also an increase in IL-12, presumably reflecting dendritic cell
priming by LPS. [25,31] Other inflammatory cytokines, IL1-b and
TNFa were elevated only in the LPS–rich challenged group.
Consistent with the neutrophilia seen in the BALF there was an
increase in the chemokine KC, an ortholog of IL-8 that is a potent
neutrophil chemoattractant. [32] It is possible that activation of
the airway epithelium by LPS may have contributed to the
elevation in KC. Activation of the nuclear factor kappa-light-
chain-enhancer of activated B cells (NFkB) pathway in the airway
epithelium has been reported following LPS challenge and is
important in mediating LPS-induced airway neutrophilia. [33]
Similarly, NFkB is activated within thirty minutes of OVA
challenge [34], potentially as a result of the LPS present in the
OVA. Both types of OVA induced the same degree of IL-5 in
TLR4-deficient mice, whereas the IL-4, IL-1b, TNF-a, KC and
IL-12p40 responses were blunted in TLR4-deficient mice,
indicating that, in particular, the pro-inflammatory cytokine
responses to OVA challenge are promoted by contaminating
LPS and TLR4. The route of sensitization may also affect the
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immune response following challenge. [23] Airway sensitization
with OVA and LPS results in a Th17 response while peritoneal
sensitization promotes a strong Th2 cytokine mediated response
[23] and the AHR produced is the result of synergy between IL-17
and Th2 cytokines. Th2 inflammation appears to have been the
dominant cause of AHR in our study and the additional
neutrophilic inflammation and augmented cytokines had only a
modest effect on the changes in resistance and no effect on
elastance in response to methacholine.
We evaluated the overall lung tissue T cell response, in wild type
mice, by lung digestion and flow cytometry. Similar to the finding
of increased total cells in BALF there was also an increase in total
cells recovered from the lung digests after LPS-rich OVA
challenge. In addition CD4+ T cells, Tregs and activated CD4+
T cells were all increased in the LPS–rich OVA challenged
animals. Although there were comparable levels of IL-2 in BALF
of both OVA challenged groups there was a greater absolute
number of CD4+CD25+FoxP32 T cells present in the LPS-rich
OVA challenged group. The increase in CD4+ T cells in the LPS-
rich OVA challenged animals is also consistent with the higher
levels of Th1 and Th2 cytokines in the BALF. Surprisingly there
was an increase in Tregs only in the LPS-rich OVA challenged
group indicating that Treg expansion or recruitment is facilitated
by LPS. This effect was also observable in vitro when murine
splenocytes were cultured with the LPS-rich OVA and could be
prevented with the TLR4 inhibitor TAK-242. Despite the
recruitment of Tregs to the lungs in animals challenged with
LPS-rich OVA, the inflammatory response was still greater than in
the LPS-free OVA challenged group. Although Tregs have been
implicated in determining the intensity and the resolution of
inflammation following pulmonary challenge with antigen. [35–
37] they appear to have little role to play in the acute response to
allergen challenge of a sensitized animal but are rather important
for the development of tolerance to chronic allergen challenge.
[38] Interestingly, Whitehead et al. recently reported that while the
addition of a low-moderate concentration of LPS during intranasal
OVA sensitization (comparable to the LPS concentrations found
in ovalbumin in our study) promoted more substantial acute
airway inflammation than lower levels of LPS, this concentration
of LPS also induced Tregs and, after multiple allergen challenges,
shorter-lived asthma-like features than in mice sensitized with
lower doses of LPS [22]. Whereas LPS levels were modified during
OVA sensitization but were equivalent during challenge, in our
study, we demonstrate in identically sensitized animals that the
induction of Foxp3-expressing Tregs is apparently entirely
dependent on the contaminating LPS and TLR4 signaling
associated with the inhalational allergen challenge, rather than
the adjuvant effect of alum or LPS during intraperitoneal
sensitization. Taken together, although it is not clear whether
the Tregs in both studies are functionally equivalent, their
expansion in response to inhaled antigen appears to depend on
concomitant airway exposure to sufficient levels of LPS irrespec-
tive of whether this exposure coincides with sensitization or
challenge. It is not clear whether the lack of resolution of airway
disease and thus apparent absence of an inhibitory effect of the
LPS-induced Tregs in our model may be due to a requirement for
prior airway exposure to LPS and OVA (such as during
sensitization), due to a need for more allergen challenges
(premature experimental endpoint), higher dose of LPS and
threshold of Tregs, or perhaps due to the alum-mediated pro-
inflammatory response overcoming the inhibitory capacity of the
induced Tregs. Finally, whether the induction of Tregs depends on
TLR4 receptors on dendritic cells or T cells requires further
exploration.
We tested also the response of human peripheral blood
mononuclear cells (PBMC) to LPS-free and LPS-rich OVA to
determine if a pattern of response specific to LPS-rich OVA was
present in vitro. The LPS-free OVA did not induce any cytokine
response whereas the LPS-rich preparation induced pro-inflam-
matory cytokines comparable to the effects of 100 ng of E coli LPS.
It is interesting to note that both IFN-c and IL-1b are significantly
increased by the LPS-rich OVA even compared to pure LPS.
MyD88-dependent signalling by both IFN-c and LPS has been
shown to induce steroid resistant AHR via IL-27 producing
pulmonary macrophages. [39] IL-1b is released from the
inflammasome upon Nod-like receptor stimulation by microbial
molecules [40], of which LPS is one of many. This increased IFN-
c and IL-1b level would suggest that the commercial LPS-rich
OVA may also contain other microbial-derived molecules which
may induce inflammation and confound the immune response to
the OVA allergen.
In the absence of adjuvant, stimulation of TLR4 on airway
structural cells has been shown to be necessary for priming of
innate immune responses and for the development of airway
disease in response to inhaled house dust mite allergen (HDM).
[41] Indeed HDM and LPS airway sensitization and challenge
reduced Th2 responses and enhanced Th1 inflammatory respons-
es, increasing both TNFa and IL-17 secretion. [42] Recently, Tan
et al., have also reported that TLR4 expression on stromal cells
promotes Th2-biased allergic sensitization to OVA via the airways
and the development of subsequent airway disease. [43] The levels
of contaminating LPS in our study are comparable to the low-
moderate level referred to by Tan et al. Here, we show that
systemic OVA sensitization in conjunction with an exogenous
adjuvant (alum) leads to AHR that is largely independent of the
contaminating endotoxin and TLR4 signaling. However, our data
reveal that although i.p. OVA sensitization with alum can elicit
subsequent allergic airway disease independently of TLR4, as has
been previously reported, this does not mean that the contami-
nating LPS in OVA and associated TLR4 signaling are devoid of
any influence upon the ensuing allergen challenge-associated
inflammatory response in an alum-dependent OVA-asthma
model. Indeed, observations regarding the phenomenon of LPS
tolerance by both Peters et al [44] and more recently by Chapman
et al, [45] elegantly demonstrate the significant effect of repeated
exposure to LPS and the respective LPS levels have on the
cytokine levels and allergic lung response. LPS tolerance also
results in long lasting effects on murine macrophage gene
expression and phenotypes. [46] Therefore, our study provides a
degree of refinement in our understanding of the mechanisms
underlying such experimental asthma models. Specifically, in
agreement with Tan et al., despite the sensitization with alum
adjuvant, we find that the associated Th2 inflammatory response
remains partially dependent on the contaminating endotoxin
present with OVA allergen challenge. Significantly, the inflam-
matory cytokine, T regulatory cell, and neutrophil responses
Figure 5. LPS-rich OVA induces a cytokine response in human PBMCs similar to LPS. PBMCs were stimulated for 20 hrs with saline, LPS-
free OVA, LPS-rich OVA and LPS, the supernatants were the analysed by MSD electrochemical ELISA for the levels of secreted cytokines, (a) IL-12p40,
(b) TNFa (c) IFNc, (d) IL-1b, (e) IL-2, (f) IL4, (g) IL-5 and (h) IL-10. Values are shown as Mean6 SEM. (n = 6). Statistical significance was determined using
ANOVA.
doi:10.1371/journal.pone.0098648.g005
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associated with OVA challenge are completely dependent on the
presence of contaminating endotoxin and signaling via TLR4, and
independent of the alum sensitization. We confirmed that these
findings could be recapitulated with peripheral blood mononucle-
ar cells.
In conclusion, LPS-contamination of commercial OVA is a
confounding variable in the interpretation of studies of experi-
mental asthma. The results of the current study show that the
pattern and degree of inflammation in an alum-dependent OVA-
asthma model, particularly neutrophil, lymphocyte and Treg
responses, is substantially influenced by the presence of LPS
specifically during the pulmonary antigen challenge.
Supporting Information
Figure S1 Timeline of OVA challenge comparing LPS-
rich and LPS-free OVA preparations. Mice were acclimated
for 1 week prior to i.p. sensitization with 10 mg of OVA (Grade V,
Sigma) in aluminum hydroxide. Sensitization was performed on
Day 0 and 7, on day 14 mice were intransally challenged once or
on three consecutive days with 10 mg of LPS-rich OVA (Sigma) or
LPS-free OVA (Hyglos Gmbh). One day after the single challenge
and two days following three challenges, experiments were
performed.
(TIF)
Figure S2 LAL assay analysis of endotoxin content in
LPS-rich and LPS-free OVA. LPS-rich OVA (Sigma) or LPS-
free OVA (Hyglos) samples were diluted to determine the range of
endotoxin concentration and samples were assessed using a
chromogenic LAL assay. LPS-rich, Sigma grade V, contained
0.004% endotoxin, (400 ng/10 mg OVA), while LPS-free OVA,
Hyglos-Endograde, had undetectable levels. LPS-rich OVA (light
bars), LPS-free OVA (dark bars). Values are shown as Mean 6
SEM, (n = 5).
(TIF)
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